Related Experiment Video
Updated: Aug 18, 2026
Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
Published on: June 13, 2018
Understanding mesenchymal cancer: the liposarcoma-associated FUS-DDIT3 fusion gene as a model
P A Pérez-Mancera1, I Sánchez-García
1Instituto de Biologia Molecular y Celular del Cancer (IBMCC), CSIC/Universidad de Salamanca, 37007-Salamanca, Spain.
Abstract:
Chromosomal translocations entail the generation of gene fusions in mesenchymal tumors. Despite the successful identification of these specific and consistent genetic events, the nature of the intimate association between the gene fusion and the resulting phenotype still remains to be elucidated. Here these studies are reviewed, using FUS-DDIT3 as a model to illustrate how they have contributed to current understanding in unique and unexpected ways. FUS-DDIT3 is a chimeric oncogene generated by the most common chromosomal translocation t(12;16)(q13;p11) associated with liposarcomas. The application of transgenic methods to the study of this sarcoma-associated FUS-DDIT3 gene fusion has provided insights into their functions in vivo, and suggested mechanisms by which lineage selection may be achieved.
Insights
Gene fusions like FUS-DDIT3, resulting from chromosomal translocations in tumors, are linked to specific phenotypes. Studies using FUS-DDIT3 in liposarcomas reveal insights into oncogene function and cell lineage selection in vivo.
Area of Science:
- Oncology
- Genetics
- Molecular Biology
Background:
- Chromosomal translocations are key events in mesenchymal tumor development, often creating specific gene fusions.
- While gene fusions are identified, their precise role in tumor phenotype development remains unclear.
- The FUS-DDIT3 fusion oncogene, from translocation t(12;16), is common in liposarcomas.
Purpose of the Study:
- To review studies on gene fusions in mesenchymal tumors.
- To use FUS-DDIT3 as a model to understand the link between gene fusions and tumor phenotypes.
- To explore the in vivo functions of FUS-DDIT3 and its role in cell lineage selection.
Main Methods:
- Review of existing scientific literature.
- Analysis of studies employing transgenic methods.
- Investigation of FUS-DDIT3 function in vivo.
Main Results:
- Transgenic studies of FUS-DDIT3 have provided in vivo insights into its function.
- The research suggests mechanisms by which FUS-DDIT3 influences cell lineage selection.
- Understanding FUS-DDIT3 contributes to the broader knowledge of sarcoma pathogenesis.
Conclusions:
- FUS-DDIT3 serves as a valuable model for understanding gene fusion roles in cancer.
- In vivo studies are crucial for elucidating the functional impact of oncogenic fusions.
- Further research can uncover mechanisms of lineage selection driven by specific gene fusions.
